Low-add Multifocal vs. Monofocal IOLs

NCT ID: NCT03749161

Last Updated: 2018-11-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-04-01

Study Completion Date

2020-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Compare low-add multifocal IOLs with monofocal IOLs to evaluate if patients in the low-add multifocal IOL group have better unaided distance visual acuity compared to the monofocal group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Spectacle independence is one of the main aims in modern cataract surgery. Although bilateral monofocal IOL implantation, aiming for emmetropia or low myopia, leads to high levels of patient satisfaction in distance vision, spectacle dependence for intermediate vision, reading and other near vision tasks is the usual result.

There are different techniques to reduce spectacle dependence, the most common one is the use of multifocal IOLs. However, a variable number of patients complain of problems, such as glare or haloes (positive dysphotopsia symptoms). Dysphotopsia symptoms may vary significantly from patient to patient. The real incidence of dysphotopsia like symptoms after cataract surgery and multifocal IOL is unknown and the implantation of multifocal IOLs is a commonly accepted contraindication in patients who are night drivers. Another characteristic of many multifocal IOLs is that it can provide patients with excellent near and distance vision but lack in the intermediate range.

One option to enhance intermediate vision and to leave patients with good contrast sensitivity is the use of low-add multifocal IOLs. These IOLs are adequate to expectations a lot of patients have, who were used to have a good distance vision and who were wearing spectacles when performing near vision tasks before surgery. Many of these patients would prefer to keep their reading spectacles after surgery and ideally would like to function well at distance and intermediate (60 to 80 cm - computer distance, household work…) range without glasses.

One example of these low-add multifocal IOLs is the LENTIS Comfort MF15 with a near add of 1.50D (on IOL plane). Its single, blended transition zone works to deliver patients the same kind of distance vision as a monofocal IOL with the addition of enhanced intermediate vision. In particular, this design provides improved vision at a distance of 60 cm and more. Additional key features of the Comfort IOL include good contrast sensitivity for twilight vision, optimized depth of focus, and natural imaging quality and color sensitivity. Especially this type of IOL may lead to more tolerance of postoperative refractive errors due to biometry and IOL power calculation imprecision. This should result in better unaided distance vision and therefore higher patient satisfaction after cataract surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lentis comfort

Patient will receive the low-add multifocal IOL during cataract surgery

Group Type EXPERIMENTAL

Low-add multifocal IOL

Intervention Type DEVICE

Lentis comfort, low-add multifocal, IOL

Lentis L-313

Patient will receive the monofocal IOL Lentis L-313 during cataract surgery

Group Type EXPERIMENTAL

Monofocal IOL

Intervention Type DEVICE

Lentis L-313, monofocal IOL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low-add multifocal IOL

Lentis comfort, low-add multifocal, IOL

Intervention Type DEVICE

Monofocal IOL

Lentis L-313, monofocal IOL

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age-related cataract in both eyes
* Scheduled for bilateral cataract surgery
* Motivated to be less spectacle dependant in the distance to intermediate vision range
* Patients with an expected BCDVA of 0.8 snellen score or better after surgery
* Patients with the need of an IOL Power in the range of 10 to 30D (biometry performed with the IOL master 700)
* Age 21 and older
* Written informed consent prior to recruitment

Exclusion Criteria

* Pregnancy (pregnancy test will be taken pre-operatively in women of reproductive age)
* Retinopathia pigmentosa
* Chronic uveitis
* Amblyopia
* Pupil decentration \> 1mm center shift
* preceded retinal surgery
* preceded Laser-in-situ-Keratomileusis (LASIK)
* Any ophthalmic abnormality that could compromise visual function or the measurements
Minimum Eligible Age

21 Years

Maximum Eligible Age

105 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Prim. Prof. Dr. Oliver Findl, MBA

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prim. Prof. Dr. Oliver Findl, MBA

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vienna Institute for Research in Ocular Surgery (VIROS)

Vienna, , Austria

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Austria

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

John Falasinnu, MD

Role: CONTACT

01 / 91021 / 57559

Nino Hirnschall, MD

Role: CONTACT

01 / 91021 / 57562

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

John Falasinnu, MD

Role: primary

01 / 91021 / 57559

Nino Hirnschall, MD

Role: backup

01 / 91021 / 57562

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Oculentis

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

EDoF IOLs vs Monofocal IOL
NCT03172351 COMPLETED NA
EDOF and Multifocal IOL Study
NCT05573529 COMPLETED NA
Photopic and Mesopic Multifocal IOL Performance
NCT06978556 ACTIVE_NOT_RECRUITING